{{Rsnum
|rsid=4666360
|Chromosome=2
|position=20135948
|Orientation=plus
|GMAF=0.4803
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 9.7 | 42.5 | 47.8
| HCB | 65.4 | 29.3 | 5.3
| JPT | 58.9 | 37.5 | 3.6
| YRI | 47.9 | 43.2 | 8.9
| ASW | 26.3 | 47.4 | 26.3
| CHB | 65.4 | 29.3 | 5.3
| CHD | 69.7 | 27.5 | 2.8
| GIH | 31.0 | 52.0 | 17.0
| LWK | 36.7 | 47.7 | 15.6
| MEX | 22.4 | 41.4 | 36.2
| MKK | 25.6 | 46.8 | 27.6
| TSI | 3.0 | 41.6 | 55.4
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=C
  |Pval=3E-6
  |OR=2.14
  |ORtxt=[1.546-2.95]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}